Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19378 | 443 | 43.7 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
332 | 17329 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ACYLATION STIMULATING PROTEIN | Author keyword | 89 | 84% | 11% | 48 |
2 | C3ADESARG | Author keyword | 73 | 96% | 5% | 23 |
3 | MIKE ROSENBLOOM CARDIOVASC | Address | 12 | 29% | 7% | 33 |
4 | ACYLATION STIMULATING PROTEIN ASP | Author keyword | 6 | 80% | 1% | 4 |
5 | C5L2 | Author keyword | 5 | 43% | 2% | 9 |
6 | COMPLEMENT C3A | Author keyword | 4 | 41% | 2% | 7 |
7 | RECH UNIV CARDIOL PNEUMOL QUEBEC | Address | 3 | 32% | 2% | 9 |
8 | C3A DESARG | Author keyword | 3 | 50% | 1% | 5 |
9 | MCGILL UNIT PREVENT CARDIOVASC DIS | Address | 3 | 57% | 1% | 4 |
10 | TRIGLYCERIDE SYNTHESIS | Author keyword | 3 | 22% | 3% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACYLATION STIMULATING PROTEIN | 89 | 84% | 11% | 48 | Search ACYLATION+STIMULATING+PROTEIN | Search ACYLATION+STIMULATING+PROTEIN |
2 | C3ADESARG | 73 | 96% | 5% | 23 | Search C3ADESARG | Search C3ADESARG |
3 | ACYLATION STIMULATING PROTEIN ASP | 6 | 80% | 1% | 4 | Search ACYLATION+STIMULATING+PROTEIN+ASP | Search ACYLATION+STIMULATING+PROTEIN+ASP |
4 | C5L2 | 5 | 43% | 2% | 9 | Search C5L2 | Search C5L2 |
5 | COMPLEMENT C3A | 4 | 41% | 2% | 7 | Search COMPLEMENT+C3A | Search COMPLEMENT+C3A |
6 | C3A DESARG | 3 | 50% | 1% | 5 | Search C3A+DESARG | Search C3A+DESARG |
7 | TRIGLYCERIDE SYNTHESIS | 3 | 22% | 3% | 13 | Search TRIGLYCERIDE+SYNTHESIS | Search TRIGLYCERIDE+SYNTHESIS |
8 | COMPLEMENT C3 | 3 | 12% | 5% | 20 | Search COMPLEMENT+C3 | Search COMPLEMENT+C3 |
9 | ADIPSIN | 2 | 23% | 2% | 8 | Search ADIPSIN | Search ADIPSIN |
10 | COMPLEMENT COMPONENT 3 | 2 | 29% | 1% | 5 | Search COMPLEMENT+COMPONENT+3 | Search COMPLEMENT+COMPONENT+3 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACYLATION STIMULATING PROTEIN | 75 | 44% | 29% | 127 |
2 | SERUM C3 | 70 | 87% | 8% | 34 |
3 | POSTPRANDIAL TRIGLYCERIDE CLEARANCE | 21 | 90% | 2% | 9 |
4 | DIFFERENTIATED HUMAN ADIPOCYTES | 15 | 71% | 3% | 12 |
5 | ASP | 13 | 36% | 7% | 29 |
6 | ADIPSIN | 12 | 37% | 6% | 26 |
7 | SERUM BASIC PROTEIN | 6 | 80% | 1% | 4 |
8 | HYPERAPOBETALIPOPROTEINEMIA | 6 | 32% | 4% | 16 |
9 | TRIGLYCERIDE CLEARANCE | 6 | 37% | 3% | 13 |
10 | COMPLEMENT C3 | 6 | 23% | 5% | 23 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The role of complement factor C3 in lipid metabolism | 2015 | 1 | 84 | 51% |
Complement C3 and cleavage products in cardiometabolic risk | 2011 | 26 | 92 | 53% |
The complement system in human cardiometabolic disease | 2014 | 5 | 209 | 42% |
Complement in atherosclerosis: friend or foe? | 2011 | 42 | 129 | 32% |
Critical review of acylation-stimulating protein physiology in humans and rodents | 2003 | 191 | 180 | 32% |
The role of complement in atherosclerosis | 2008 | 41 | 38 | 29% |
The role of the complement system in metabolic organs and metabolic diseases | 2013 | 8 | 112 | 25% |
Adipose tissue inflammation: Feeding the development of type 2 diabetes mellitus | 2013 | 5 | 82 | 32% |
The Role of Complement in the Development and Manifestation of Murine Atherogenic Inflammation: Novel Avenues | 2012 | 8 | 85 | 28% |
Acylation stimulating protein (ASP), an adipocyte autocrine: new directions | 1999 | 58 | 58 | 48% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MIKE ROSENBLOOM CARDIOVASC | 12 | 29% | 7.4% | 33 |
2 | RECH UNIV CARDIOL PNEUMOL QUEBEC | 3 | 32% | 2.0% | 9 |
3 | MCGILL UNIT PREVENT CARDIOVASC DIS | 3 | 57% | 0.9% | 4 |
4 | RECH IUCPQ | 3 | 100% | 0.7% | 3 |
5 | RECH HOP LAVAL | 3 | 32% | 1.8% | 8 |
6 | CRIUCPQ | 3 | 42% | 1.1% | 5 |
7 | SECT NUTR EPIDEMIOL | 2 | 27% | 1.6% | 7 |
8 | METAB VASC MED | 1 | 17% | 1.4% | 6 |
9 | VASC SCI SECT | 1 | 23% | 0.7% | 3 |
10 | BIOPHYS BIOSTAT INFORMAT | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000177032 | C5A//C5A RECEPTOR//C5AR |
2 | 0.0000139387 | COMPLEMENT SYNTHESIS//MRC TRANSPLANTAT TRANSPLANTAT IMMUNOL M//COMPLEMENTO |
3 | 0.0000135342 | ACUTE MYOCARDIAL DISEASE//THANATOCHEMISTRY//COMPLEMENT C9 |
4 | 0.0000114995 | HYG PUBL HLTH MED//MESOGENESIS//TOKYO HLTH ADM |
5 | 0.0000095974 | ELECTRONEGATIVE LDL//ELECTRONEGATIVE LOW DENSITY LIPOPROTEIN//ENZYMATICALLY MODIFIED LDL |
6 | 0.0000090167 | RGC 32//RESPONSE GENE TO COMPLEMENT 32//BIIG |
7 | 0.0000084131 | C3 AND C4//COMPLEMENT AND INFLAMMATION//LUPUS EXCELLENCE |
8 | 0.0000083236 | TURKISH SOC CARDIOL//EXECUTIVE STRESS//MINNESOTA CODING |
9 | 0.0000079864 | H 411E CELLS//JIANG TANG KE LI JTKL//ADIPOCYTE SECRETED FACTORS |
10 | 0.0000074139 | CD59//CRRY//CD55 |